Snowball logo
logo
SANN

Santhera Pharmaceuticals Holding AG

SANN β€’ SW
Fr16.00+Fr0.12Β  (0.76%)
πŸ’‘ Click on a row in the table to make it appear on the graph
πŸ“Š Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20212022202320242025TTM
Revenue
Total revenue
(1.595)7.473103.439.1277.19116.3
COGS
3.7673.5923.23515.5362.7278.59
Gross Profit
(5.362)3.881100.222.9614.4737.71
Operating Expenses & Income
Operating Income
(56.89)(51.98)68.84(33.38)(37.82)(71.14)
Total Operating Expenses
51.5355.8631.3456.6952.28108.9
R&D Expenses
29.7130.5418.6726.4722.2248.69
Selling General & Admin Expenses
12.7214.5621.1819.4817.5728.32
Earnings from Continuing Operations
Interest Expense
(16.42)(20.19)(21.31)(20.17)(11.56)(31.73)
Interest Income
0.00120.610.5060.9290.40916.21
Income Tax Expense
0.8090.460.0380.3120.1850.497
Net Income
Net Income
(55.53)(71.08)54.78(41.97)(49.24)(91.21)
Supplemental
EBIT
(38.29)(50.43)76.13(21.53)(37.82)(58.34)
EBITDA
(34.57)(46.78)79.17(15.89)(32.13)(47.01)
In millions of CHF, except % and values per 1 share